End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.92 USD | -4.85% | +39.50% | +120.22% |
May. 10 | ProKidney Q1 Loss Unchanged From Year Earlier | MT |
May. 10 | ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 259M |
---|---|---|---|---|---|
Net income 2024 * | -146M | Net income 2025 * | -43M | EV / Sales 2024 * | - |
Net cash position 2024 * | 178M | Net cash position 2025 * | 310M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.05
x | P/E ratio 2025 * |
-5.32
x | Employees | 163 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.55% |
Latest transcript on ProKidney Corp.
1 day | -4.85% | ||
1 week | +39.50% | ||
Current month | +89.83% | ||
1 month | +63.33% | ||
3 months | +149.68% | ||
6 months | +223.97% | ||
Current year | +120.22% |
Managers | Title | Age | Since |
---|---|---|---|
Bruce Culleton
CEO | Chief Executive Officer | 57 | 23-07-16 |
James Coulston
DFI | Director of Finance/CFO | 48 | 21-12-31 |
Joseph Stavas
CTO | Chief Tech/Sci/R&D Officer | 69 | 19-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 21-12-31 |
Brian Pereira
BRD | Director/Board Member | 65 | 21-12-31 |
John Maraganore
BRD | Director/Board Member | 60 | 22-08-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 4.055 | +6.99% | 546,776 |
24-05-16 | 3.79 | -3.32% | 412,741 |
24-05-15 | 3.92 | -4.85% | 1,434,217 |
24-05-14 | 4.12 | +33.77% | 2,703,484 |
24-05-13 | 3.08 | +9.61% | 488,210 |
End-of-day quote Nasdaq, May 14, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+120.22% | 259M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- PROK Stock